Back to Results
First PageMeta Content
National Health Service / Clinical research / Pharmaceutical industry / Clinical governance / Clinical trial / Chemotherapy / Medicine / Health / Healthcare management


[Revised] guidance for the safe delivery of systemic anti-cancer therapy
Add to Reading List

Document Date: 2012-08-03 05:41:27


Open Document

File Size: 230,53 KB

Share Result on Facebook

City

Edinburgh / /

Company

Network Pharmacists - Regional Cancer Networks / Healthcare Improvement Scotland / Chemotherapy Advisory Group / Regional Cancer Networks / SACT / /

Country

United Kingdom / Scotland / Wales / /

Event

Person Communication and Meetings / Business Partnership / FDA Phase / /

IndustryTerm

cancer network / appropriate services / clinical trial protocol / CANCER THERAPY / self management / Cancer Care / risk management / clinical governance systems / healthcare setting / administration systems / clinical governance / /

MedicalCondition

another cancer / common cancers / SACT Outwith Cancer Centres/Units / cancer / In rarer cancers / paediatric cancer / /

MedicalTreatment

biological therapies / self management / ANTI-CANCER THERAPY / chemotherapy / hormonal therapies / /

Organization

NHS Board / Safe Administration of Intrathecal Cytotoxic Chemotherapy CEL / Safe Administration of Vinca Alkaloids CEL / Welsh Assembly / Executive Steering Committee / NHS / /

Person

Harry Burns / Bill Scott / Letter / /

/

Position

professional group representative / Chief Executive / senior pharmacist and a senior nurse / consultant / action Chief / gov. uk http /

Product

SACT Prescriptions / SACT / /

Technology

5.2 SACT protocols / SACT protocols / SACT protocol / treating cancer / clinical trial protocol / approved clinical trial protocol / 5.3 SACT protocols / 5.1 SACT protocols / /

URL

http /

SocialTag